天邦食品(002124) - 2023 Q1 - 季度财报

Revenue and Profitability - The company's revenue for Q1 2023 was ¥2,173,950,218.46, representing a 32.59% increase compared to ¥1,639,594,622.68 in the same period last year[8] - The net loss attributable to shareholders was ¥663,780,161.59, a slight improvement of 1.47% from a loss of ¥673,650,083.21 in the previous year[8] - The basic earnings per share were -¥0.36, showing a 2.70% improvement from -¥0.37 in the same period last year[8] - The net loss for Q1 2023 was CNY 664,388,151.85, slightly improved from a net loss of CNY 671,194,899.77 in Q1 2022[22] - The company reported a basic and diluted earnings per share of -0.36, compared to -0.37 in the same period last year[22] Cash Flow - The net cash flow from operating activities increased by 368.52%, reaching ¥245,854,537.22, compared to a negative cash flow of ¥91,557,968.08 in the same period last year[8] - The net cash flow from operating activities for Q1 2023 was ¥245,854,537.22, a significant improvement from -¥91,557,968.08 in Q1 2022, indicating a positive turnaround in operational efficiency[25] - Total cash inflow from operating activities reached ¥3,116,676,278.53, compared to ¥2,075,908,249.83 in the previous period, reflecting a year-over-year increase of approximately 50.2%[25] - The cash outflow from operating activities was ¥2,870,821,741.31, up from ¥2,167,466,217.91, resulting in a cash outflow increase of about 32.5%[25] - The net cash flow from investing activities was ¥351,528,662.69, a recovery from -¥339,392,692.82 in the same quarter last year, showcasing improved investment returns[25] - Cash inflow from investing activities totaled ¥556,359,391.80, a substantial increase from ¥16,900,163.65 in the previous year[25] - The total cash outflow from investing activities decreased to ¥204,830,729.11 from ¥356,292,856.47, indicating a reduction in capital expenditures[25] - The net cash flow from financing activities was -¥319,741,930.83, slightly improved from -¥320,981,489.91 in Q1 2022, showing stabilization in financing operations[26] - The total cash inflow from financing activities was ¥1,639,900,000.00, compared to ¥1,496,940,500.00 in the previous period, marking an increase of approximately 9.5%[26] - The ending cash and cash equivalents balance was ¥738,486,076.05, down from ¥897,236,421.70 in the previous year, reflecting a decrease of about 17.7%[26] - The company reported a cash increase of ¥277,624,440.88 for the quarter, contrasting with a decrease of -¥751,942,270.62 in the same quarter last year, indicating a positive cash flow trend[26] Assets and Liabilities - The total assets at the end of the reporting period were ¥19,695,631,410.72, a 0.74% increase from ¥19,551,531,971.61 at the end of the previous year[8] - The total assets of Tianbang Food Co., Ltd. as of March 31, 2023, amounted to CNY 19,695,631,410.72, an increase from CNY 19,551,531,971.61 at the beginning of the year[16] - Current assets reached CNY 4,780,424,819.05, up from CNY 4,321,760,122.54 at the start of the year, indicating a growth of approximately 10.6%[16] - The company's total equity attributable to shareholders decreased by 16.96%, from ¥3,914,950,536.79 to ¥3,251,067,875.39[8] - The total equity attributable to shareholders decreased to CNY 3,251,067,875.39 from CNY 3,914,950,536.79 at the beginning of the year[20] - The company reported a decrease in total liabilities to CNY 16,375,998,584.44 from CNY 15,565,938,493.67 at the beginning of the year[20] Operational Performance - Total operating revenue for Q1 2023 reached CNY 2,173,950,218.46, a 32.5% increase from CNY 1,639,594,622.68 in the same period last year[19] - Total operating costs amounted to CNY 2,733,199,092.59, up 19.9% from CNY 2,278,962,513.71 year-on-year[20] - The company experienced a significant increase in other income to CNY 19,039,590.69 from CNY 14,955,724.01 year-on-year[20] - Research and development expenses increased to CNY 8,599,877.77, up from CNY 6,762,751.13 in the previous year, reflecting a focus on innovation[20] Investment and Financial Activities - The company reported a 111.26% increase in investment income, attributed to dividends received from joint ventures[12] - The company’s financial expenses increased by 32.42%, primarily due to higher financing interest expenses[12] - The company’s cash flow from investing activities increased by 203.58%, driven by the receipt of the final payment for the disposal of a 51% stake in Shiji Biological[12] - The company experienced a 2900.33% increase in asset impairment losses due to the provision for consumable biological asset impairment[12] - The company's long-term equity investments slightly decreased to CNY 1,340,127,099.86 from CNY 1,354,256,161.35, a decline of about 1%[16] - The company reported a significant increase in other receivables, which rose to CNY 85,950,994.85 from CNY 548,578,504.29, reflecting a decrease of approximately 84.7%[16] - Accounts receivable rose to CNY 183,296,096.17, compared to CNY 62,275,834.07 at the beginning of the year, marking an increase of approximately 194.1%[16] - Inventory increased significantly to CNY 3,144,180,128.64 from CNY 2,631,545,098.91, reflecting a rise of about 19.5%[16] - Accounts payable surged to CNY 3,386,393,713.82 from CNY 2,827,505,842.43, indicating an increase of approximately 19.7%[16] - Short-term borrowings increased to CNY 2,643,552,447.21 from CNY 2,542,442,298.34, showing a rise of about 4%[16]